Familial aggregation of Parkinson's disease: A population-based case- control study in Europe

Neurology

Volumn 52, Issue 9, 1999, Pages 1876-1882

  Elbaz, A ^a   Grigoletto, F ^b   Baldereschi, M ^c   Breteler, M M ^d   Manubens Bertran, J M ^e   Lopez Pousa, S ^f   Dartigues, J F ^f   Alperovitch A ^a   Tzourio, C ^a   Rocca, W A ^g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c CNR   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF NAVARRA   (Spain)

^f University Hospital Sta Caterina ^*

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FAMILIAL DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0033016210     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1876     Document Type: Article

References (38)

1. Gasser T, Wszolek ZK. Troffater J, et al. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 1994;36:387-396.
2. Duvoisin R, Golbe LI. Kindreds of dominantly inherited Parkinson's disease: keys to the riddle. Ann Neurol 1995;38:355-366.
3. Golbe LI, Dilorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40:767-775.
4. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
5. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
6. Smith CA, Gough AC, Leigh PN. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
7. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372.
8. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997;350: 1136-1139.
9. PlanteBordeneuve V, Taussig D, Thomas F, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997;48: 1589-1593.
10. Maraganore DM, Harding AE, Marsden CD. A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991;6:205-211.
11. Lazzarini AM. Myers RH, Zimmerman TR, et al. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology 1994;44:499-506.
12. Semchuk KM, Love EJ, Lee RG. Parkinson's disease and exposure to rural environmental factors: a population based case-control study. Can J Neurol Sci 1991;18:279-286.
13. Semchuk KM, Love EJ, Lee RG. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43: 1173-1180.
14. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
15. Mickel SF, Broste SK, Hiner BC. Lack of overlap in genetics risk for Alzheimer's disease and Parkinson's disease. Neurology 1997;48:942-949.
16. Bonifati V, Fabrizio E, Vanacore N, De Mari M, Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci 1995;22:272-279.
17. De Michele G, Filla A, Volpe G, Cogliettino A, Ambrosio G, Campanella G. Etiology of Parkinson's disease-the role of environment and heredity. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, eds. Parkinson's disease. Philadelphia: Lippincott-Raven, 1996:19-24.
18. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155-160.
19. de Rijk MC, Tzourio C, Breteler MMB, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatry 1997;62:10-15.
20. Tzourio C, Rocca WA, Breteler MMB. et al. Smoking and Parkinson's disease: an age-dependent effect? Neurology 1997; 49:1267-1272.
21. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. J Psychiatr Res 1975;12:189-198.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., revised. Washington DC: American Psychiatric Association, 1987.
23. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press, 1993.
24. Breslow NE, Day NE. The analysis of case-control studies. Lyon, France: IARC Scientific Publications, 1980.
25. Schlesselman JJ. Case-controls studies: design, conduct, analysis. New York: Oxford University Press, 1982.
26. SAS Institute Inc. SAS user's guide: statistics. 6th ed. Cary, NC: SAS Institute, 1990.
27. Marder K, Mejia H, Ottman R, et al. Validity of a family history questionnaire for diagnosis of Parkinson's disease. Neurology 1998;50(suppl 4):A372. Abstract.
28. Sackett DL. Bias in analytic rersearch. J Chron Dis 1979;32: 51-63.
29. Rajput AH, Fenton ME, George D, Rajput A , Wilson W, McCulloch L. Concordance of common movement disorders among familial cases. Mov Disord 1997;12:747-751.
30. Koller WC. How accurately can Parkinson's disease be diagnosed? Neurology 1992;42:6-16.
31. Van Duijn CM, Clayton D, Chandra V, et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20(suppl 2): S13-20.
32. Hubble JP, Cao T, Hassanein RE, Neuberger JS, Koller WC. Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
33. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland L. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994;44:1872-1877.
34. Susser E, Susser M. Familial aggregation studies: a note on their epidemiological properties. Am J Epidemiol 1989;129: 23-30.
35. Khoury MJ, Flanders WD. Bias in using family history as a risk factor in case-control studies of disease. Am J Epidemiol 1995;6:511-519.
36. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;6:1275-1284.
37. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;8:650-658.
38. Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 1988;127:674-683.